DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
EPZ-5676
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPZ-5676
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYPERICIN
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Lymphoma, T-Cell, Cutaneous
Unknown
HYPERICIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7V2F1075HD
Molecule Type:
Small molecule
Molecular Formula:
C30H16O8
Molecular Weight:
504.45
AlogP:
5.08
PSA:
155.52
HBD:
6.0
HBA:
#RotB:
0.0
Source:
TALETRECTINIB ADIPATE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TALETRECTINIB ADIPATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H34FN5O5
Molecular Weight:
551.62
AlogP:
4.43
PSA:
77.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
KL-1333
1
Small molecule
Investigational
Unknown
Unknown
MELAS Syndrome; Mitochondrial Diseases
Unknown
KL-1333
×
Maximum Phase:
1
First Approval:
None
UNII:
NA2ZOL5UGM
Molecule Type:
Small molecule
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.26
AlogP:
2.58
PSA:
62.82
HBD:
1.0
HBA:
#RotB:
1.0
Source:
FOSIFLOXURIDINE NAFALBENAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Neoplasms
Unknown
FOSIFLOXURIDINE NAFALBENAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
4YO6QT3SZ9
Molecule Type:
Small molecule
Molecular Formula:
C29H29FN3O9P
Molecular Weight:
613.54
AlogP:
3.4
PSA:
158.18
HBD:
3.0
HBA:
#RotB:
11.0
Source:
ROCACETRAPIB
1
Small molecule
Investigational
Unknown
Unknown
Lipid Metabolism Disorders
Cholesteryl ester transfer protein inhibitor
ROCACETRAPIB
×
Maximum Phase:
1
First Approval:
None
UNII:
K9SP3L3YQP
Molecule Type:
Small molecule
Molecular Formula:
C31H34F7NO3
Molecular Weight:
601.6
AlogP:
9.54
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
6.0
Source:
ZK200775
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ZK200775
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROPYL GALLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PROPYL GALLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
8D4SNN7V92
Molecule Type:
Small molecule
Molecular Formula:
C10H12O5
Molecular Weight:
212.2
AlogP:
1.37
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
3.0
Source:
MK-3281
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
MK-3281
×
Maximum Phase:
1
First Approval:
None
UNII:
3593C180JO
Molecule Type:
Small molecule
Molecular Formula:
C29H37N3O3
Molecular Weight:
475.63
AlogP:
5.31
PSA:
57.94
HBD:
1.0
HBA:
#RotB:
6.0
Source:
E7107
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E7107
×
Maximum Phase:
1
First Approval:
None
UNII:
R60DZX1E2N
Molecule Type:
Small molecule
Molecular Formula:
C40H66N2O9
Molecular Weight:
718.97
AlogP:
5.05
PSA:
152.53
HBD:
4.0
HBA:
#RotB:
10.0
Source:
GSK159802
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
GSK159802
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ILX23-7553
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vitamin D receptor agonist
ILX23-7553
×
Maximum Phase:
1
First Approval:
None
UNII:
O13QTC8612
Molecule Type:
Small molecule
Molecular Formula:
C27H38O3
Molecular Weight:
410.6
AlogP:
4.85
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
3.0
Source:
SIBOFIMLOC
1
Small molecule
Investigational
Unknown
Unknown
Crohn Disease
Unknown
SIBOFIMLOC
×
Maximum Phase:
1
First Approval:
None
UNII:
00OF00QZC4
Molecule Type:
Small molecule
Molecular Formula:
C35H39NO11
Molecular Weight:
649.69
AlogP:
-2.02
PSA:
200.61
HBD:
8.0
HBA:
#RotB:
2.0
Source:
RALANITEN ACETATE
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms
Unknown
RALANITEN ACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
L10K286T2H
Molecule Type:
Small molecule
Molecular Formula:
C27H33ClO8
Molecular Weight:
521.01
AlogP:
4.44
PSA:
97.36
HBD:
0.0
HBA:
#RotB:
13.0
Source:
HYODEOXYCHOLIC_ACID
1
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia
LXR-alpha agonist
HYODEOXYCHOLIC_ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
7A33Y6EHYK
Molecule Type:
Small molecule
Molecular Formula:
C24H40O4
Molecular Weight:
392.58
AlogP:
4.48
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
4.0
Source:
QC-12
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
QC-12
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALTIRATINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
ALTIRATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
T678746713
Molecule Type:
Small molecule
Molecular Formula:
C26H21F3N4O4
Molecular Weight:
510.47
AlogP:
5.0
PSA:
109.42
HBD:
3.0
HBA:
#RotB:
8.0
Source:
RO4987655
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RO4987655
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06282999
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-06282999
×
Maximum Phase:
1
First Approval:
None
UNII:
YO3O4Q2NC8
Molecule Type:
Small molecule
Molecular Formula:
C13H12ClN3O3S
Molecular Weight:
325.78
AlogP:
1.72
PSA:
90.11
HBD:
2.0
HBA:
#RotB:
4.0
Source:
LISAVANBULIN
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Neoplasms
Unknown
LISAVANBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
5PT0QP06X5
Molecule Type:
Small molecule
Molecular Formula:
C26H29N9O3
Molecular Weight:
515.58
AlogP:
2.69
PSA:
190.77
HBD:
4.0
HBA:
#RotB:
13.0
Source:
VINPOCETINE
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Attention Deficit Disorder with Hyperactivity
Unknown
VINPOCETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
543512OBTC
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O2
Molecular Weight:
350.46
AlogP:
4.15
PSA:
34.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PYRUVATE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis
Unknown
PYRUVATE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
POD38AIF08
Molecule Type:
Small molecule
Molecular Formula:
C3H3NaO3
Molecular Weight:
110.04
AlogP:
-0.34
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
SX-682
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Pancreatic Ductal; Melanoma; Myelodysplastic Syndromes; Pulmonary Disease, Chronic Obstructive; Rectal Neoplasms
Interleukin-8 receptors, CXCR1/CXCR2 inhibitor
SX-682
×
Maximum Phase:
1
First Approval:
None
UNII:
H5212R2DPM
Molecule Type:
Small molecule
Molecular Formula:
C19H14BF4N3O4S
Molecular Weight:
467.21
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AZELOPRAZOLE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux
Unknown
AZELOPRAZOLE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
KDJ60607ON
Molecule Type:
Small molecule
Molecular Formula:
C22H26N3NaO4S
Molecular Weight:
451.52
AlogP:
3.66
PSA:
86.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ALEPLASININ
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Plasminogen activator inhibitor-1 inhibitor
ALEPLASININ
×
Maximum Phase:
1
First Approval:
None
UNII:
LL56J87F3X
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3
Molecular Weight:
425.53
AlogP:
6.23
PSA:
59.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
RG7893
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG7893
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
URAPIDIL HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Aneurysm, Dissecting
Unknown
URAPIDIL HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
PVU92PZO12
Molecule Type:
Small molecule
Molecular Formula:
C20H30ClN5O3
Molecular Weight:
423.95
AlogP:
0.72
PSA:
71.74
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ILS-920
1
Small molecule
Investigational
Unknown
Unknown
Ischemic Stroke
Unknown
ILS-920
×
Maximum Phase:
1
First Approval:
None
UNII:
F2D5P81X82
Molecule Type:
Small molecule
Molecular Formula:
C58H88N2O14
Molecular Weight:
1037.34
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BDTX189
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Epidermal growth factor receptor erbB1 negative allosteric modulator
BDTX189
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H29ClN6O4
Molecular Weight:
561.04
AlogP:
4.84
PSA:
110.73
HBD:
2.0
HBA:
#RotB:
11.0
Source:
NMS-1116354
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cell division cycle 7-related protein kinase inhibitor
NMS-1116354
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KW-2478
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma
Unknown
KW-2478
×
Maximum Phase:
1
First Approval:
None
UNII:
QY50S617NM
Molecule Type:
Small molecule
Molecular Formula:
C30H42N2O9
Molecular Weight:
574.67
AlogP:
2.27
PSA:
127.23
HBD:
2.0
HBA:
#RotB:
16.0
Source:
PHA-793887
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
PHA-793887
×
Maximum Phase:
1
First Approval:
None
UNII:
MKS45S912B
Molecule Type:
Small molecule
Molecular Formula:
C19H31N5O2
Molecular Weight:
361.49
AlogP:
2.31
PSA:
81.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
INDIBULIN
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms
Tubulin inhibitor
INDIBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
80K4H2RB8P
Molecule Type:
Small molecule
Molecular Formula:
C22H16ClN3O2
Molecular Weight:
389.84
AlogP:
4.56
PSA:
63.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
58
59
60
61
62
63
64
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA